Investigations in a model of Alzheimer disease suggested that Ripk1 regulates DAM gene expression, including Cst7 and Ch25h (34)—findings that prompted our exploration of Ripk1 as a potential modulator of these genes and DAM-associated markers in Krabbe and Sandoff disease. Here, RIPK1 is linked to early-onset autosomal dominant Alzheimer disease.